Background
==========

Atherosclerosis is an inflammatory disease that involves the accumulation of fibrous and/or fatty components in the intima of medium and large arteries such as the coronary artery, carotid artery, and peripheral artery, and the clinical manifestations vary with the arteries affected \[[@b1-medscimonit-26-e921692],[@b2-medscimonit-26-e921692]\]. Ischemic strokes and transient ischemic attacks may occur if the carotid artery is involved, and carotid atherosclerotic disease accounts for approximately 18--25% of all ischemic strokes \[[@b3-medscimonit-26-e921692]\]. Prevention of stroke in patients with carotid atherosclerosis depends on the degree of carotid stenosis. These preventive methods mainly include carotid endarterectomy, carotid stenting, and medical management such as with statins and antiplatelet agents \[[@b4-medscimonit-26-e921692],[@b5-medscimonit-26-e921692]\]. Although the medical management is effective and may even serve as an alternative to carotid endarterectomy in patients with asymptomatic carotid atherosclerosis, patients who are nonresponsive to medical therapies or not tolerant of the adverse effects may not benefit from present medical therapies \[[@b6-medscimonit-26-e921692]--[@b8-medscimonit-26-e921692]\]. Therefore, elucidating the molecular mechanism of the pathogenesis and progression of carotid atherosclerosis and identifying new potential molecular targets for medical therapies that can slow progression of carotid atherosclerosis and prevent ischemic events are quite important. The molecular mechanism mainly includes abnormal accumulation of lipids, immune response, and inflammation, and monocytes play an important role \[[@b1-medscimonit-26-e921692],[@b9-medscimonit-26-e921692]\]. Induced by chemokines, circulating monocytes can bind to adhesion molecules expressed by endothelial cells, migrating into the arterial wall and differentiating into macrophages. Previous studies focused on the role of circulating monocytes in the pathogenesis and progression of carotid atherosclerosis; however, few researchers have used weighted (gene) correlation network analysis (WGCNA) to construct gene co-expression networks for carotid atherosclerosis based on high-throughput data of peripheral blood mononuclear cells (PBMCs) in patients.

Zhang and Horvath first developed the WGCNA algorithm in 2005, which can be used for gene co-expression network construction, gene module detection, and hub gene identification, based on gene expression data \[[@b10-medscimonit-26-e921692]--[@b12-medscimonit-26-e921692]\]. Furthermore, gene modules and hub genes can be correlated with clinical traits if these data are available. The WGCNA R package was developed on the official R website (*<https://cran.r-project.org/>*), making it more convenient for researchers to conduct WGCNA. Although WGCNA was first developed for analyzing gene expression data, it can also be used for miRNA, lncRNA, and even metabolome \[[@b13-medscimonit-26-e921692]--[@b15-medscimonit-26-e921692]\].

Previous studies screened differentially expressed genes (DEGs) using microarray data of carotid atherosclerotic plaques. For instance, Razuvaev et al. identified 11 downregulated genes and 19 upregulated genes by comparing the gene expression profile between symptomatic and asymptomatic patients \[[@b16-medscimonit-26-e921692]\]. However, DEG screening cannot reveal the interaction among genes or identify genes with crucial biological functions.

In the present study, we focused on the possible underlying molecular mechanism of the occurrence of ischemic events. The mRNA microarray data of the Biobank of Karolinska Endarterectomies (BiKE) were included. The expression data of peripheral blood mononuclear cells for patients with ischemic events (the events group) and patients without ischemic events (the no-events group) during follow-up \[[@b17-medscimonit-26-e921692]\] were used in our analysis. The genes in the gene modules were subjected to functional enrichment analysis. Then, we mapped DEGs into the co-expression network of events group and obtained 1 DEG co-expression network. Furthermore, we identified crucial genes based on the DEG co-expression network. The potential diagnostic and prognostics values of the upregulated crucial genes were identified.

Material and Methods
====================

Datasets
--------

The dataset GSE21545, from the Biobank of Karolinska Endarterectomy (BiKE), was selected from the Gene Expression Omnibus (GEO) (*<http://www.ncbi.nlm.nih.gov/geo/>*). Series matrix file and platform data tables (GPL570) were downloaded.

DEG analysis
------------

The series matrix file was annotated with GPL570 platform data tables, and the probe names in the matrix file were replaced by the gene symbols. Then, the 97 peripheral blood mononuclear cell (PBMC) samples were included in our analysis, in which 21 were samples of the events group and 76 were samples of the no-events group. Differentially expressed genes (DEGs) were screened using the "limma" R package. \|log~2~(fold-change)\|\>2 and adjusted p\<0.01 were set as the threshold of DEG screening.

Construction of co-expression network by WGCNA
----------------------------------------------

Co-expression networks for both PBMC and plaque samples were constructed using the "WGCNA" R package. The algorithm filtered genes with the top 25% variance for further analysis, and WGCNA analysis was conducted for the events group (21 samples) and the no-events group (76 samples). The soft-power threshold β was chosen to ensure a scale-free topology. A topological overlap measure (TOM) matrix was created from the adjacency matrix to estimate the network's connectivity property. A clustering dendrogram was constructed using average linkage hierarchical clustering based on the TOM matrix. The threshold for modules size was set as 50 for both groups to generate modules with proper size, and similar modules were merged.

GO and KEGG pathway enrichment of gene modules
----------------------------------------------

Gene ontology (GO) and Kyoto Encyclopedia of Genes Genomes (KEGG) pathway analyses were conducted for genes in modules we detected using the Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8 (*<https://david.ncifcrf.gov/>*) to determine the biological function and signaling pathway involved in these modules. Count number \>2 and p\<0.05 were set as thresholds for the analysis. The differences between co-expression networks for the events group and no-events group were compared based on the results of functional enrichment analysis.

Identification of hub genes and crucial genes
---------------------------------------------

Hub genes were considered to be the gene which had the largest intramodular connectivity in each module. Then, we mapped the DEGs into a co-expression network in the events group using Cytoscape v3.7.0, and we obtained 1 DEG co-expression network. Isolated nodes and isolated nodes pairs were removed from the network. The Molecular Complex Detection (MCODE), a plugin in Cytoscape to detect core subnetworks, was used to identify crucial gene clusters based on the DEG co-expression network. Receiver operating characteristic (ROC) analysis and survival analysis were also conducted using the combination of the upregulated genes in the crucial gene cluster by SPSS 25.0 to show the potential diagnostic and prognostic value of upregulated crucial genes.

Results
=======

Flowchart
---------

The flowchart of our study is shown in [Figure 1](#f1-medscimonit-26-e921692){ref-type="fig"}. We constructed the co-expression networks for the events group and no-events group and detected gene modules. Then, DEG screening was conducted, and 183 DEGs were screened. The DEG co-expression network were constructed by mapping DEGs into the whole co-expression network of the events group. Based on the DEG co-expression network, crucial genes were identified, and their clinical significance was evaluated by ROC and survival analysis.

Screening of DEGs
-----------------

With the threshold of \|log~2~(fold-change)\|\>2 and p\<0.01, 183 DEGs were screened with 122 upregulated and 61 downregulated genes. The heatmap and the volcano plot showed the expression pattern of DEGs ([Figure 2](#f2-medscimonit-26-e921692){ref-type="fig"}). Upregulated DEGs and downregulated DEGs with the top 10-fold-change are shown in [Supplementary Table 1](#s2-medscimonit-26-e921692){ref-type="supplementary-material"}.

Construction of the co-expression network for the events group and no-events group
----------------------------------------------------------------------------------

One outlier (GSM892524) in the events group was removed, while all samples in the no-events group were included for further analysis, as shown in the sample clustering dendrogram ([Figure 3A](#f3-medscimonit-26-e921692){ref-type="fig"} and [Supplementary Figure 1A](#s1-medscimonit-26-e921692){ref-type="supplementary-material"}). The power of β=10 and 16 were chosen as the soft-threshold for the network of the events group and no-events group, respectively ([Figure 3B](#f3-medscimonit-26-e921692){ref-type="fig"} and [Supplementary Figure 1B](#s1-medscimonit-26-e921692){ref-type="supplementary-material"}). And the both the co-expression networks we constructed met the requirements of scale-free topology ([Figure 3C--3E](#f3-medscimonit-26-e921692){ref-type="fig"} and [Supplementary Figure 1C--1E](#s1-medscimonit-26-e921692){ref-type="supplementary-material"}). We detected 8 gene modules for the events group and 6 gene modules for the no-events group ([Figure 3F](#f3-medscimonit-26-e921692){ref-type="fig"} and [Supplementary Figure 1F](#s1-medscimonit-26-e921692){ref-type="supplementary-material"}).

Comparison of co-expression patterns
------------------------------------

KEGG pathway and GO-BP analysis were used to assess the biological function of genes for modules. Results of GO-BP and KEGG analyses are shown in Supplementary Tables 2 and [3](#s2-medscimonit-26-e921692){ref-type="supplementary-material"}. The green-yellow module may be related to the occurrence of ischemic events. The green-yellow module is mainly associated with inflammation and immune response. Nonetheless, pathways associated with inflammation and immune response were scattered in modules of the no-events group. The KEGG pathway GO-BP terms with the top 10 count numbers for green-yellow modules of the events group are shown in [Figure 4](#f4-medscimonit-26-e921692){ref-type="fig"} and [Table 1](#t1-medscimonit-26-e921692){ref-type="table"}. These results indicate that PBMC might play a role in the occurrence of ischemic events through regulating inflammation and immune response.

Hub genes in modules of the events group and no-events group
------------------------------------------------------------

Hub genes for modules of the events group and no-events group are shown in [Table 2](#t2-medscimonit-26-e921692){ref-type="table"}. The hub genes of the green-yellow modules of the events group were killer cell immunoglobulin-like receptor, 2 Ig domains, and long cytoplasmic tail 5A (*KIR2DL5A*), which are killer cell immunoglobulin-like receptors (KIRs) and are mainly expressed by natural killer cells and subsets of T cells.

Identification of crucial genes mediating ischemic events
---------------------------------------------------------

The DEG co-expression network was obtained by mapping DEGs into the whole co-expression network of the events group. The threshold for weighted edge was set as 0.1. After removing isolated nodes and isolated nodes pairs, a network with 16 nodes and 24 edges was generated ([Figure 5A](#f5-medscimonit-26-e921692){ref-type="fig"}). MCODE detected 1 significant cluster consisting of 5 genes for the DEG co-expression network ([Figure 5B](#f5-medscimonit-26-e921692){ref-type="fig"}, [Table 3](#t3-medscimonit-26-e921692){ref-type="table"}). Among these 5 genes, 2 genes were upregulated (*THRAP3* and *RBM43*) and 3 genes were downregulated (*SIRT1*, *PEX1*, and *KLHDC2*). Sirtuin 1 (*SIRT1*), a member of the sirtuin family, had the highest connectivity among the 5 crucial genes.

Combination of the 2 upregulated genes showed potential diagnostic and prognostic value ([Figure 6](#f6-medscimonit-26-e921692){ref-type="fig"}).

Discussion
==========

We screened 183 DEGs, among which 122 were upregulated and 61 were downregulated ([Figure 2](#f2-medscimonit-26-e921692){ref-type="fig"} and [Supplementary Table 1](#s2-medscimonit-26-e921692){ref-type="supplementary-material"}). Weighted co-expression networks were constructed using the WGCNA algorithm. We detected 8 modules for the events group and 6 modules for the no-events group.

We also conducted KEGG pathway and GO-BP analysis (Supplementary Tables 2 and [3](#t3-medscimonit-26-e921692){ref-type="table"}) and found that pathways related to inflammation and immune response were mainly enriched in the green-yellow module of the events group. However, these pathways were dispersed in modules of the no-events group. Hub genes were considered to be genes which had the highest connectivity in each module ([Table 2](#t2-medscimonit-26-e921692){ref-type="table"}). Then, the DEG co-expression network was obtained by mapping DEGs into the whole co-expression network of the events group, and crucial genes were identified by MCODE based on the DEG co-expression network. These crucial genes were *THRAP3, RBM43, SIRT1, PEX1*, and *KLHDC2. SIRT1* had the highest connectivity among the 5 crucial genes, and the combination of 2 upregulated genes (*THRAP3* and *RBM43*) showed potential prognostic and diagnostic value.

Perisic et al. used the same dataset and analyzed the expression signature of PBMCs, and the DEGs they screened were different from the DEGs in our study. They grouped patients into a symptomatic group and an asymptomatic group. In the symptomatic group, patients already had plaque instability, which was defined as transient ischemic attack (TIA), minor stroke (MF), and amaurosis fugax (AF) \[[@b18-medscimonit-26-e921692]\]. However, unlike the previous study, we classified patients into an events group and a no-events group, depending on the occurrence of ischemic events during follow-up \[[@b17-medscimonit-26-e921692]\]. The difference in grouping patients may account for the difference in DEG screening results.

Several previous studies conducted WGCNA on expression data of atherosclerosis. Using aortic samples from Apob^tm2Sgy^Ldlr^tm1Her^ knockout mice, Deshpande et al. discovered that inflammation and immune response might play a role in the pathogenesis and progression of atherosclerosis, and identified several related genes *(TM9SF1, LEPR*, *WIF1, and SP1*). In contrast to the sample Desphande et al. used, some researchers used human atherosclerotic samples from the GEO website and also found that inflammation and immune response might have important roles. Zhang et al. discovered crucial genes such as *TNPO1* and *ZDHHC17*, while Wang et al. found that a lncRNA module was associated with inflammation and immune response. However, they did not elucidate the molecular mechanism based on the expression profiling of PBMC samples, and the grouping was also different \[[@b19-medscimonit-26-e921692]--[@b22-medscimonit-26-e921692]\].

The gene module detection and functional enrichment analysis indicated that the co-expression patterns in the events group and no-events group were different. We found that inflammation and immune response were clustered in the green-yellow module of the events group. A previous study showed that CD14^+^CD16^--^ monocyte has a proinflammatory phenotype, and increased circulating proinflammatory monocytes were observed in the atherosclerotic models of ApoE^--/--^ mice \[[@b23-medscimonit-26-e921692],[@b24-medscimonit-26-e921692]\]. Belge et al. also discovered that proinflammatory cytokines such as TNF-α can be produced by activated CD14^hi^CD16^+^ monocytes, which might participate in atherosclerosis progression \[[@b25-medscimonit-26-e921692]\]. In addition, monocytes are involved in regulation of immune response in atherosclerosis. Some tissue macrophages and dendritic cells in the lesion originated from monocytes \[[@b26-medscimonit-26-e921692],[@b27-medscimonit-26-e921692]\]. Evans et al. found that T cell response can be regulated by monocytes \[[@b28-medscimonit-26-e921692]\]. Furthermore, the *TLR-4* expression in CD14^hi^CD16^+^ monocytes were correlated with occurrence of plaque progression and ischemic events in coronary artery disease \[[@b29-medscimonit-26-e921692]\]. In a recent experimental study, Bruen et al. showed that conjugated linoleic acid (CLA), which is an anti-inflammatory lipid, can induce regression of atherosclerosis in ApoE^--/--^ mice. In mice fed CLA, more monocytes differentiated into anti-inflammatory M2 macrophages \[[@b30-medscimonit-26-e921692]\]. Sun et al. fed ApoE^--/--^ model mice phenytoin, a non-selective voltage-gated sodium channels antagonist, and the mice subsequently exhibited increased levels of anti-inflammatory monocytes and decreased levels of proinflammatory monocytes \[[@b31-medscimonit-26-e921692]\]. Statins were also found to affect monocytes in atherosclerosis. Using samples from patients, Gasbarrino et al. discovered that intensive statins therapy can downregulate the expression of the anti-inflammatory adiponectin-AdipoR pathway in monocytes and macrophages, instead of positively regulating this pathway, which may explain part of the residual cardiovascular risk in patients using statins \[[@b32-medscimonit-26-e921692]\]. These studies, together with our findings, suggest that monocytes participate in the pathogenesis and progression of atherosclerosis via mediating inflammation and immune response, both directly and indirectly.

The hub gene of the green-yellow module was *KIR2DL5A*, belonging to the KIR family, and it is mainly expressed by natural killer cells and T cells. *KIR2DL5A* is an inhibitory receptor of immune response \[[@b33-medscimonit-26-e921692]\] and it is involved in immune response to viral infection and prognosis of certain malignant diseases. Shan et al. reported that patients with *KIR2DL5A^--^/2DL5B^+^* genotype had increased HCV clearance \[[@b34-medscimonit-26-e921692]\]. In colorectal cancer, the presence of *KIR2DL5A* is related to increased complete response rate in patients treated with FOLFIRI chemotherapy \[[@b35-medscimonit-26-e921692]\], and *KIR2DL5A* is also a protective factor against breast cancer \[[@b36-medscimonit-26-e921692]\], while in pediatric leukemia patients after hematopoietic stem cell transplantation, the presence of *KIR2DL5A* is associated with higher relapse rate \[[@b37-medscimonit-26-e921692]\]. However, few studies had reported the role of *KIR2DL5A* in monocytes or its role in atherosclerosis, and it might be a promising target to elucidate the molecular mechanism for the progression of carotid atherosclerosis.

*SIRT1* was the gene having the highest degree among the 5 crucial genes, and it was downregulated in the events group. *SIRT1* is a type of NAD-dependent histone deacetylase \[[@b38-medscimonit-26-e921692]\] and participates in regulating inflammation, apoptosis, and cell senescence \[[@b39-medscimonit-26-e921692],[@b40-medscimonit-26-e921692]\]. It also plays roles in stress response, aging, and longevity \[[@b41-medscimonit-26-e921692],[@b42-medscimonit-26-e921692]\]. *SIRT1* can also slow the progression of atherosclerosis by lipid modification, oxidative stress reduction, anti-inflammatory actions, foam cells, and autophagy regulation, and downregulation of *SIRT1* was observed in a atherosclerotic mouse model \[[@b43-medscimonit-26-e921692]\], which is consistent with our findings. Recently, Lee et al. discovered that *SIRT1* inhibits the adhesion of monocytes to vascular endothelia cells by suppressing *MAC-1* expression in monocytes \[[@b44-medscimonit-26-e921692]\]. In addition, Nguyen et al. discovered that a dipeptidyl peptidase 4 inhibitor, evogliptin, can inhibit monocytes adhesion to vascular endothelial cells in an ApoE^--/--^ mouse model, and this effect is associated with regulation of *NF-*κ*B* by *SIRT1* \[[@b45-medscimonit-26-e921692]\]. Therefore, *SIRT1* might also slow the progression of atherosclerosis by preventing monocytes adhesion, which is the one of the initiation steps in the pathogenesis of atherosclerosis.

The upregulated genes, *THRAP3* and *RBM43*, showed potential diagnostic and prognostic value. *THRAP3*, thyroid hormone receptor-associated protein 3, is an RNA-processing factors and can also participate in the DNA damage response (DDR) pathway and transcription regulation \[[@b46-medscimonit-26-e921692]--[@b49-medscimonit-26-e921692]\]. Mutations in *THRAP3* may cause DNA damage repair defects, and Vohhodina reported that loss of *THRAP3* made 293T and U2OS cells more susceptible to DNA-damaging factors \[[@b49-medscimonit-26-e921692]\]. Ino et al. used LNCaP and LNCaP-AI prostate cancer cell lines to demonstrate that *THRAP3* phosphorylation can contribute to the acquisition of androgen independence in prostate cancer via transcriptional regulation \[[@b48-medscimonit-26-e921692]\]. Another study, using high-fat-fed mice, found that *THRAP3* can act as a transcriptional regulator in diabetes and can control diabetic gene programming \[[@b47-medscimonit-26-e921692]\]. *RBM43* is an RNA binding motif protein 43 and its detailed biological function is not known. At present, it is unclear whether *THRAP3* and *RBM43* participates the pathogenesis of atherosclerosis, although they were found to have potential clinical significance for the occurrence of ischemic events in carotid atherosclerosis patients.

In the present study, for the first time, we constructed a co-expression network, detected genes modules, and identified hub genes and crucial genes in carotid atherosclerosis using PBMC expression data. However, datasets in GEO lack clinical information; therefore, it is difficult to correlate traits with clinical importance with gene modules in WGCNA analysis.

The events group and no-events group had different co-expression patterns, and these differences suggest that monocytes are of vital importance in the pathogenesis and progression of carotid atherosclerosis via mediating inflammation and immune response. Then, we identified hub genes and crucial genes, which might have crucial biological functions in the pathogenesis of carotid atherosclerosis or potential diagnostic and prognostic value for ischemic events.

Conclusions
===========

We detected 8 modules for the events group and 6 modules for the no-events group. The hub genes for each module and crucial genes of the DEG co-expression network were also identified. These genes might serve as potential targets for medical therapies and as biomarkers for diagnosis and prognosis. Further mechanism studies are needed to explore the biological function of these genes in the pathogenesis and progression of carotid atherosclerosis.

Supplementary Data
==================

###### 

WGCNA of no-event. (**A**) No outlier was detected by sample clustering. (**B, C**) Selection of soft-threshold β. (**D, E**) Fitness of scale free topology when β-16. (**F**) Cluster dendrogram. Each module was represented by WGCNA.

###### 

Top10 up-regulated and down-regulated DEGs.

  Gene symbol          Official full gene name                                      log2 (fold-change) (patients with events/patients without events)
  -------------------- ------------------------------------------------------------ -------------------------------------------------------------------
  **Up-regulated**                                                                  
  TNFAIP6              TNF alpha induced protein 6                                  9.968020902
  PTX3                 Pentraxin 3                                                  8.826641354
  RNASE2               Ribonuclease A family member 2                               7.978917622
  KCNJ2                Potassium inwardly rectifying channel subfamily J member 2   7.481378497
  SERPINB2             Serpin family B member 2                                     7.18837765
  PLA2G7               Phospholipase A2 group VII                                   6.901998631
  BCL2A1               BCL2 related protein A1                                      6.719719825
  CLEC4D               C-type lectin domain family 4 member D                       6.272368641
  SAMSN1               SAM domain, SH3 domain and nuclear localization signals 1    6.209244405
  GPR84                G protein-coupled receptor 84                                5.186451434
  **Down-regulated**                                                                
  KLRC3                Killer cell lectin like receptor C3                          −7.246559422
  BTN3A2               Butyrophilin subfamily 3 member A2                           −7.003853494
  ANKRD20A11P          Ankyrin repeat domain 20 family member A11, pseudogene       −6.02418399
  ZNF600               Zinc finger protein 600                                      −5.985685983
  NLRC3                NLR family CARD domain containing 3                          −5.579931019
  LCK                  LCK proto-oncogene, Src family tyrosine kinase               −4.825468373
  GOLGA8N              Golgin A8 family member N                                    −4.799854266
  CEP78                Centrosomal protein 78                                       −4.795917474
  SLC9A3R1             SLC9A3 regulator 1                                           −4.381636674
  SEP1                 Septin 1                                                     −4.097540674

###### 

KEGG pathways for modules of events group and no-events group.

  Events group   KEGG ID           KEGG pathway                                   Count   −logP   No-events group   KEGG ID      KEGG pathway                                                 Count   −logP
  -------------- ----------------- ---------------------------------------------- ------- ------- ----------------- ------------ ------------------------------------------------------------ ------- -------
                 **Black**                                                                                          **Black**                                                                         
                 hsa05034          Alcoholism                                     14      4.58                      hsa04611     Platelet activation                                          11      5.10
                 hsa05322          Systemic lupus erythematosus                   13      5.13                      hsa05322     Systemic lupus erythematosus                                 11      4.98
                 hsa04611          Platelet activation                            11      3.80                      hsa05034     Alcoholism                                                   11      3.94
                 hsa05203          Viral carcinogenesis                           10      1.82                      hsa04512     ECM-receptor interaction                                     8       3.83
                 hsa05202          Transcriptional misregulation in cancer        9       1.87                      hsa05203     Viral carcinogenesis                                         8       1.71
                 hsa04062          Chemokine signaling pathway                    9       1.62                      hsa04510     Focal adhesion                                               8       1.70
                 hsa04512          ECM-receptor interaction                       6       1.62                      hsa04810     Regulation of actin cytoskeleton                             8       1.66
                 hsa04540          Gap junction                                   6       1.60                      hsa04540     Gap junction                                                 6       2.20
                 hsa05219          Bladder cancer                                 4       1.38                      hsa04670     Leukocyte transendothelial migration                         6       1.73
                 **Blue**                                                                                           hsa05410     Hypertrophic cardiomyopathy (HCM)                            5       1.70
                 hsa01100          Metabolic pathways                             218     3.72                      hsa05414     Dilated cardiomyopathy                                       5       1.59
                 hsa05166          HTLV-I infection                               49      1.56                      hsa04640     Hematopoietic cell lineage                                   5       1.54
                 hsa04144          Endocytosis                                    48      1.76                      hsa04530     Tight junction                                               5       1.54
                 hsa04141          Protein processing in endoplasmic reticulum    45      4.34                      hsa05130     Pathogenic Escherichia coli infection                        4       1.52
                 hsa01130          Biosynthesis of antibiotics                    45      2.15                      hsa00590     Arachidonic acid metabolism                                  4       1.32
                 hsa05016          Huntington's disease                           38      1.42                      **Green**                                                                         
                 hsa04932          Non-alcoholic fatty liver disease (NAFLD)      36      2.60                      hsa04151     PI3K-Akt signaling pathway                                   16      1.30
                 hsa05168          Herpes simplex infection                       36      1.33                      hsa04144     Endocytosis                                                  15      2.22
                 hsa00190          Oxidative phosphorylation                      31      2.13                      hsa04141     Protein processing in endoplasmic reticulum                  13      2.66
                 hsa04110          Cell cycle                                     30      2.30                      hsa05166     HTLV-I infection                                             13      1.35
                 hsa04380          Osteoclast differentiation                     30      1.96                      hsa04510     Focal adhesion                                               12      1.60
                 hsa03040          Spliceosome                                    30      1.87                      hsa04380     Osteoclast differentiation                                   11      2.52
                 hsa05012          Parkinson's disease                            30      1.51                      hsa04640     Hematopoietic cell lineage                                   9       2.61
                 hsa05161          Hepatitis B                                    30      1.40                      hsa04722     Neurotrophin signaling pathway                               9       1.78
                 hsa04142          Lysosome                                       27      1.65                      hsa05220     Chronic myeloid leukemia                                     8       2.48
                 hsa00240          Pyrimidine metabolism                          25      2.09                      hsa05230     Central carbon metabolism in cancer                          7       2.11
                 hsa01200          Carbon metabolism                              25      1.51                      hsa05212     Pancreatic cancer                                            7       2.08
                 hsa04660          T cell receptor signaling pathway              23      1.58                      hsa05100     Bacterial invasion of epithelial cells                       7       1.71
                 hsa05132          Salmonella infection                           22      2.21                      hsa05132     Salmonella infection                                         7       1.59
                 hsa05323          Rheumatoid arthritis                           20      1.36                      hsa04210     Apoptosis                                                    6       1.57
                 hsa03018          RNA degradation                                19      1.62                      hsa04662     B cell receptor signaling pathway                            6       1.40
                 hsa04210          Apoptosis                                      18      2.26                      hsa04962     Vasopressin-regulated water reabsorption                     5       1.50
                 hsa05131          Shigellosis                                    18      2.11                      hsa00510     N-Glycan biosynthesis                                        5       1.36
                 hsa00510          N-Glycan biosynthesis                          16      2.54                      magenta                                                                           
                 hsa05221          Acute myeloid leukemia                         15      1.60                      hsa04670     Leukocyte transendothelial migration                         7       2.60
                 hsa05134          Legionellosis                                  14      1.39                      hsa04142     Lysosome                                                     7       2.48
                 hsa00280          Valine, leucine and isoleucine degradation     13      1.50                      hsa04810     Regulation of actin cytoskeleton                             7       1.39
                 hsa00520          Amino sugar and nucleotide sugar metabolism    13      1.43                      hsa04015     Rap1 signaling pathway                                       7       1.39
                 hsa05340          Primary immunodeficiency                       12      2.19                      hsa03008     Ribosome biogenesis in eukaryotes                            6       2.41
                 hsa00071          Fatty acid degradation                         12      1.49                      hsa05131     Shigellosis                                                  5       2.14
                 hsa00640          Propanoate metabolism                          10      1.86                      hsa04520     Adherens junction                                            5       1.98
                 hsa03060          Protein export                                 9       1.92                      hsa05100     Bacterial invasion of epithelial cells                       5       1.84
                 **Green**                                                                                          hsa05132     Salmonella infection                                         5       1.75
                 hsa05166          HTLV-I infection                               9       1.36                      hsa01200     Carbon metabolism                                            5       1.33
                 hsa03040          Spliceosome                                    8       2.34                      hsa04710     Circadian rhythm                                             4       2.22
                 hsa05010          Alzheimer's disease                            8       1.81                      hsa05130     Pathogenic Escherichia coli infection                        4       1.63
                 hsa04110          Cell cycle                                     6       1.36                      hsa04621     NOD-like receptor signaling pathway                          4       1.53
                 hsa00310          Lysine degradation                             5       2.07                      **Red**                                                                           
                 hsa04115          p53 signaling pathway                          5       1.70                      hsa01100     Metabolic pathways                                           36      3.34
                 **Greenyellow**                                                                                    hsa05010     Alzheimer's disease                                          13      4.71
                 hsa04650          Natural killer cell mediated cytotoxicity      19      14.53                     hsa05016     Huntington's disease                                         13      4.14
                 hsa04612          Antigen processing and presentation            15      12.70                     hsa00190     Oxidative phosphorylation                                    12      4.96
                 hsa04060          Cytokine-cytokine receptor interaction         11      3.16                      hsa05012     Parkinson's disease                                          12      4.69
                 hsa04062          Chemokine signaling pathway                    7       1.59                      hsa04932     Non-alcoholic fatty liver disease (NAFLD)                    9       2.46
                 hsa05142          Chagas disease (American trypanosomiasis)      5       1.42                      hsa03010     Ribosome                                                     8       2.14
                 hsa05332          Graft-versus-host disease                      4       2.13                      hsa03050     Proteasome                                                   4       1.44
                 hsa05330          Allograft rejection                            4       1.99                      hsa00520     Amino sugar and nucleotide sugar metabolism                  4       1.35
                 hsa04940          Type I diabetes mellitus                       4       1.84                      **Tan**                                                                           
                 hsa05321          Inflammatory bowel disease (IBD)               4       1.37                      hsa01100     Metabolic pathways                                           147     2.23
                 **Magenta**                                                                                        hsa04120     Ubiquitin mediated proteolysis                               36      7.03
                 hsa04010          MAPK signaling pathway                         7       1.45                      hsa03013     RNA transport                                                33      3.48
                 hsa04664          Fc epsilon RI signaling pathway                4       1.55                      hsa04141     Protein processing in endoplasmic reticulum                  30      2.64
                 **Pink**                                                                                           hsa03040     Spliceosome                                                  25      2.57
                 hsa05168          Herpes simplex infection                       8       1.91                      hsa04110     Cell cycle                                                   22      1.99
                 hsa04931          Insulin resistance                             6       1,80                      hsa03018     RNA degradation                                              21      4,38
                 hsa04145          Phagosome                                      7       1,78                      hsa05161     Hepatitis B                                                  21      1,09
                 hsa00190          Oxidative phosphorylation                      6       1,46                      hsa04114     Oocyte meiosis                                               18      1,33
                 **Red**                                                                                            hsa03015     mRNA surveillance pathway                                    17      1,78
                 hsa01100          Metabolic pathways                             37      2.07                      hsa04070     Phosphatidylinositol signaling system                        17      1.50
                 hsa04114          Oocyte meiosis                                 8       2.17                      hsa04668     TNF signaling pathway                                        17      1.20
                 hsa04120          Ubiquitin mediated proteolysis                 8       1.70                      hsa04066     HIF-1 signaling pathway                                      15      1.04
                 hsa04668          TNF signaling pathway                          7       1.69                      hsa04720     Long-term potentiation                                       14      1.93
                 hsa01200          Carbon metabolism                              7       1.59                      hsa04115     p53 signaling pathway                                        13      1.51
                 hsa04722          Neurotrophin signaling pathway                 7       1.48                      hsa05120     Epithelial cell signaling in Helicobacter pylori infection   13      1.51
                 hsa04666          Fc gamma R-mediated phagocytosis               6       1.58                      hsa04210     Apoptosis                                                    12      1.40
                 hsa05230          Central carbon metabolism in cancer            5       1.41                      hsa00562     Inositol phosphate metabolism                                12      1.04
                 hsa05211          Renal cell carcinoma                           5       1.37                      hsa00520     Amino sugar and nucleotide sugar metabolism                  11      1.75
                 hsa00010          Glycolysis / Gluconeogenesis                   5       1.35                      hsa05130     Pathogenic Escherichia coli infection                        11      1.58
                 hsa04662          B cell receptor signaling pathway              5       1.31                      hsa05110     Vibrio cholerae infection                                    11      1.52
                 hsa00512          Mucin type O-Glycan biosynthesis               4       1.63                      hsa00510     N-Glycan biosynthesis                                        10      1.30
                 hsa00620          Pyruvate metabolism                            4       1.34                      hsa00280     Valine, leucine and isoleucine degradation                   9       1.05
                 **Yellow**                                                                                         hsa03420     Nucleotide excision repair                                   9       1.05
                 hsa05152          Tuberculosis                                   21      4.97                      hsa03060     Protein export                                               8       2.26
                 hsa04142          Lysosome                                       19      6.25                      hsa03430     Mismatch repair                                              6       1.15
                 hsa04145          Phagosome                                      19      4.88                      **Yellow**                                                                        
                 hsa05164          Influenza A                                    17      3.05                      hsa05166     HTLV-I infection                                             16      2.96
                 hsa05166          HTLV-I infection                               17      1.50                      hsa05152     Tuberculosis                                                 11      2.00
                 hsa04380          Osteoclast differentiation                     16      3.92                      hsa04010     MAPK signaling pathway                                       11      1.08
                 hsa05162          Measles                                        15      3.31                      hsa04145     Phagosome                                                    10      2.01
                 hsa01130          Biosynthesis of antibiotics                    15      1.52                      hsa05168     Herpes simplex infection                                     10      1.50
                 hsa04640          Hematopoietic cell lineage                     14      4.68                      hsa05203     Viral carcinogenesis                                         10      1.24
                 hsa05140          Leishmaniasis                                  13      4.92                      hsa05161     Hepatitis B                                                  9       1.64
                 hsa05323          Rheumatoid arthritis                           13      3.96                      hsa05164     Influenza A                                                  9       1.24
                 hsa05145          Toxoplasmosis                                  12      2.54                      hsa05140     Leishmaniasis                                                8       2.83
                 hsa04064          NF-kappa B signaling pathway                   11      2.80                      hsa04660     T cell receptor signaling pathway                            8       2.00
                 hsa05150          *Staphylococcus aureus* infection              10      3.77                      hsa05169     Epstein-Barr virus infection                                 8       1.57
                 hsa04066          HIF-1 signaling pathway                        10      1.99                      hsa05162     Measles                                                      8       1.39
                 hsa04620          Toll-like receptor signaling pathway           10      1.72                      hsa04612     Antigen processing and presentation                          7       2.02
                 hsa04612          Antigen processing and presentation            9       2.11                      hsa05145     Toxoplasmosis                                                7       1.32
                 hsa04666          Fc gamma R-mediated phagocytosis               9       1.86                      hsa03040     Spliceosome                                                  7       1.00
                 hsa04660          T cell receptor signaling pathway              9       1.45                      hsa05332     Graft-versus-host disease                                    6       2.99
                 hsa04672          Intestinal immune network for IgA production   8       2.75                      hsa05330     Allograft rejection                                          6       2.76
                 hsa05134          Legionellosis                                  8       2.40                      hsa04940     Type I diabetes mellitus                                     6       2.51
                 hsa05321          Inflammatory bowel disease (IBD)               8       1.99                      hsa03050     Proteasome                                                   6       2.42
                 hsa01230          Biosynthesis of amino acids                    8       1.73                      hsa05320     Autoimmune thyroid disease                                   6       2.11
                 hsa05133          Pertussis                                      8       1.64                      hsa05416     Viral myocarditis                                            6       1.94
                 hsa05204          Chemical carcinogenesis                        8       1.50                      hsa05323     Rheumatoid arthritis                                         6       1.22
                 hsa00480          Glutathione metabolism                         7       1.92                      hsa05310     Asthma                                                       5       2.27
                 hsa05416          Viral myocarditis                              7       1.69                      hsa04672     Intestinal immune network for IgA production                 5       1.59
                 hsa05310          Asthma                                         6       2.31                      hsa05223     Non-small cell lung cancer                                   5       1.35
                 hsa05332          Graft-versus-host disease                      5       1.46                      hsa05321     Inflammatory bowel disease (IBD)                             5       1.17
                 hsa00920          Sulfur metabolism                              4       2.42                      hsa04662     B cell receptor signaling pathway                            5       1.08
                 hsa00511          Other glycan degradation                       4       1.54                      hsa01230     Biosynthesis of amino acids                                  5       1.03
                                                                                                                    hsa03022     Basal transcription factors                                  4       1.03

**Source of support:** This work was supported by the Natural Science Foundation of China (81770481 and 51890894), the Natural Science Foundation of Beijing (7172171), and the CAMS Innovation Fund for Medical Sciences (CIFMS, 2017-I2M-1-008)

**Supplemenatry Table 2:** GO-BP terms for modules of events group and no events group.

Supplementary/raw data available from the corresponding author on request.
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![DEG screening. (**A**) Heatmap for the DEGs we screened. (**B**) Volcano plots for the DEGs. The X-axis represents --log(P.val) and Y-axis represents logFC.](medscimonit-26-e921692-g002){#f2-medscimonit-26-e921692}

![WGCNA of event group. (**A**) One outlier (GSE89254) was delected by sample clustering. (**B, C**) Selection of soft-threshold β. (**D, E**) Fitness for scale free topology when β 10. (**F**) Cluster dendrogram. Each module was represented by WGCNA.](medscimonit-26-e921692-g003){#f3-medscimonit-26-e921692}

![Enriched GO-BP terms and KEGG pathways with top10 count number for greenyellow module of events group. (**A**) GO-BP terms; (**B**) KEGG terms.](medscimonit-26-e921692-g004){#f4-medscimonit-26-e921692}

![DEG co-expression network and crucial genes. (**A**) Red boxes represent up-regulated genes. Green boxes represent down-regulated genes. (**B**) Crucial genes generated by MCODE.](medscimonit-26-e921692-g005){#f5-medscimonit-26-e921692}

![ROC and survival analysis of up-regulated crucial genes.](medscimonit-26-e921692-g006){#f6-medscimonit-26-e921692}

###### 

GO-BP KEGG pathways terms with top 10 count number of black module for events group.

  ID            Terms                                          Count   −LogP
  ------------- ---------------------------------------------- ------- -------
  **GO-BP**                                                            
  GO: 0006955   Immune response                                24      11.80
  GO: 0007165   Signal transduction                            24      3.82
  GO: 0050776   Regulation of immune response                  18      12.65
  GO: 0007186   G-protein coupled receptor signaling pathway   15      1.63
  GO: 0006954   Inflammatory response                          14      4.60
  GO: 0007166   Cell surface receptor signaling pathway        13      5.34
  GO: 0045087   Innate immune response                         12      2.89
  GO: 0006915   Apoptotic process                              12      1.99
  GO: 0006968   Cellular defense response                      9       7.24
  GO: 0008284   Positive regulation of cell proliferation      9       1.31
  **KEGG**                                                             
  hsa04650      Natural killer cell mediated cytotoxicity      19      14.53
  hsa04612      Antigen processing and presentation            15      12.70
  hsa04060      Cytokine-cytokine receptor interaction         11      3.16
  hsa04062      Chemokine signaling pathway                    7       1.59
  hsa05142      Chagas disease (American trypanosomiasis)      5       1.42
  hsa05332      Graft-versus-host disease                      4       2.13
  hsa05330      Allograft rejection                            4       1.99
  hsa04940      Type I diabetes mellitus                       4       1.84
  hsa05321      Inflammatory bowel disease (IBD)               4       1.37

###### 

Hub genes of each module for events group and no-events group.

  Module                Gene symbol   Official full gene name
  --------------------- ------------- ---------------------------------------------------------------------------------------
  **Events group**                    
  Black                 ACRBP         Acrosin binding protein
  Blue                  AP2M1         Adaptor related protein complex 2 subunit mu 1
  Green                 DOCK10        Dedicator of cytokinesis 10
  Greenyellow           KIR2DL5A      Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A
  Magenta               GNS           Glucosamine (N-acetyl)-6-sulfatase
  Pink                  FHOD1         Formin homology 2 domain containing 1
  Red                   ITGA5         Integrin subunit alpha 5
  Yellow                MPEG1         Macrophage expressed 1
  **No-events group**                 
  Black                 CTTN          Cortactin
  Green                 PRKCSH        Protein kinase C substrate 80K-H
  Magenta               MAPRE1        Microtubule associated protein RP/EB family member 1
  Red                   FAM103A1      RNA Guanine-7 Methyltransferase Activating Subunit
  Tan                   ZHX1          Zinc fingers and homeoboxes 1
  Yellow                ZBTB20        Zinc finger and BTB domain containing 20

###### 

Crucial genes detected by MCODE.

  Entrez ID   Gene symbol   Official full gene name
  ----------- ------------- -----------------------------------------------
  23411       SIRT1         Sirtuin 1
  9967        THRAP3        Thyroid Hormone Receptor Associated Protein 3
  375287      RBM43         RNA Binding Motif Protein 43
  23588       KLHDC2        Kelch Domain Containing 2
  5189        PEX1          Peroxisomal Biogenesis Factor 1
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